Press Release: RedHill : RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the Company...
Read full article »
Co-Founder & CEO
Dror Ben-Asher
RedHill is an Israel-based pharmaceutical company that researches and develops small-molecule therapeutics for the treatment of gastrointestinal and infectious diseases.
Read more